Home LiteratureArticle Details
PMID: 16282454 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.

Journal of virology ·Vol. 79 ·No. 23 ·2005-12-00 ·Pages 14546-54

Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN

Abstract

The T-cell-mediated resolution of herpes simplex virus type 2 (HSV-2) genital infections is not fully understood. In these studies, the mechanisms by which CD8+ T cells clear virus from the genital epithelium were examined. Ovalbumin (OVA)-specific CD8+ T cells from OT-I transgenic mice cleared a thymidine kinase-deficient, ovalbumin-expressing HSV-2 virus (HSV-2 tk- OVA) from the genital epithelium of recipient mice, and clearance was abrogated by in vivo neutralization of gamma interferon (IFN-gamma). Further, CD8+ OT-I T cells deficient in IFN-gamma were unable to clear HSV-2 tk- OVA from the vaginal epithelium. The requirement for cytolytic mechanisms in HSV-2 tk- OVA clearance was tested in radiation chimeras by adoptive transfer of wild-type or perforin-deficient OT-I T cells to irradiated Fas-defective or wild-type recipients. Although a dramatic decrease in viral load was observed early after challenge with HSV-2 tk- OVA, full resolution of the infection was not achieved in recipients lacking both perforin- and Fas-mediated cytolytic pathways. These results suggest that IFN-gamma was responsible for an early rapid decrease in HSV-2 virus titer. However, either perforin- or Fas-mediated cytolytic mechanisms were required to achieve complete clearance of HSV-2 from the genital epithelium.

MeSH Terms
Animals CD8-Positive T-Lymphocytes/immunology Herpes Genitalis/immunology,virology Herpesvirus 2, Human/immunology Membrane Glycoproteins/immunology Mice Mice, Knockout Perforin Pore Forming Cytotoxic Proteins T-Lymphocytes, Cytotoxic/immunology fas Receptor/immunology
Chemicals
Membrane Glycoproteins Pore Forming Cytotoxic Proteins fas Receptor Perforin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dobbs Melanie E
Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Strasser Jane E
Chu Chin-Fun
Chalk Claudia
Milligan Gregg N
References (53)
53 references, click to expand
  1. Herpes simplex virus turns off the TAP to evade host immunity.
    Nature. 1995 Jun 1;375(6530):411-5 PMID: 7760935
  2. Theiler's virus infection of perforin-deficient mice.
    J Virol. 1998 May;72(5):4515-9 PMID: 9557751
  3. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses.
    Curr Opin Immunol. 1996 Aug;8(4):472-7 PMID: 8794015
  4. Role of interferon-gamma in immunity to herpes simplex virus.
    J Leukoc Biol. 1996 Oct;60(4):528-32 PMID: 8864138
  5. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.
    Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8 PMID: 9023344
  6. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
    Virology. 1997 Mar 3;229(1):259-68 PMID: 9123869
  7. Homeostatic regulation of CD8+ T cells by perforin.
    Eur J Immunol. 1999 Oct;29(10):3262-72 PMID: 10540338
  8. Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2.
    Immunology. 2000 Apr;99(4):540-5 PMID: 10792501
  9. Immune protection against HSV-2 in B-cell-deficient mice.
    Virology. 2000 May 10;270(2):454-63 PMID: 10793004
  10. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.
    J Virol. 2000 Dec;74(23):11215-21 PMID: 11070019
  11. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
    Pharmacol Ther. 1998 May;78(2):55-113 PMID: 9623881
  12. Role of mucosal immunity in herpes simplex virus infection.
    J Immunol. 1998 Jun 15;160(12):5998-6003 PMID: 9637514
  13. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    J Immunol. 1998 Jun 15;160(12):6093-100 PMID: 9637526
  14. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
    Cancer Res. 1998 Jul 1;58(13):2832-7 PMID: 9661898
  15. Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells.
    J Immunol. 1999 Jan 15;162(2):957-64 PMID: 9916720
  16. An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.
    J Virol. 1999 Mar;73(3):2058-63 PMID: 9971787
  17. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice.
    J Virol. 1999 Jun;73(6):5196-200 PMID: 10233988
  18. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.
    J Interferon Cytokine Res. 1999 Apr;19(4):295-308 PMID: 10334380
  19. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
    Virology. 1999 Jun 5;258(2):282-94 PMID: 10366565
  20. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.
    J Virol. 1999 Aug;73(8):6380-6 PMID: 10400730
  21. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina.
    J Reprod Immunol. 2001 Jan;49(1):49-65 PMID: 11137112
  22. HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas.
    J Immunol. 2001 Oct 1;167(7):3928-35 PMID: 11564811
  23. Antiviral actions of interferons.
    Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents PMID: 11585785
  24. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    J Immunol. 2002 Jan 15;168(2):834-8 PMID: 11777979
  25. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.
    J Virol. 2002 Nov;76(22):11541-50 PMID: 12388715
  26. Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei: protective role of gamma interferon.
    Infect Immun. 2003 Jan;71(1):465-73 PMID: 12496197
  27. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase.
    J Immunol. 2003 Dec 15;171(12):6733-41 PMID: 14662877
  28. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.
    J Virol. 2004 Mar;78(5):2530-6 PMID: 14963155
  29. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.
    J Virol. 2004 Mar;78(5):2632-6 PMID: 14963171
  30. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites.
    J Virol. 2004 Apr;78(8):4185-96 PMID: 15047834
  31. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    J Reprod Immunol. 2004 Apr;61(2):115-27 PMID: 15063634
  32. Latent herpes simplex virus and the nervous system,.
    Curr Top Microbiol Immunol. 1975;70:31-50 PMID: 169103
  33. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.
    J Immunol. 1984 Jan;132(1):197-202 PMID: 6418797
  34. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.
    J Virol. 1984 Sep;51(3):747-53 PMID: 6088797
  35. Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo.
    J Biol Chem. 1984 Nov 10;259(21):13451-7 PMID: 6490660
  36. Evolution of recurrent herpes simplex lesions. An immunohistologic study.
    J Clin Invest. 1985 Jan;75(1):226-33 PMID: 3880773
  37. The LMP antigens: a stable MHC-controlled multisubunit protein complex.
    Hum Immunol. 1986 Apr;15(4):416-26 PMID: 3700147
  38. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.
    Virology. 1991 Jul;183(1):1-11 PMID: 1711253
  39. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells.
    J Immunol. 1992 Nov 15;149(10):3297-301 PMID: 1385520
  40. Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis.
    J Immunol. 1993 May 15;150(10):4303-14 PMID: 8482837
  41. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.
    Science. 1993 Sep 10;261(5127):1445-8 PMID: 7690156
  42. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.
    J Virol. 1994 Jan;68(1):48-55 PMID: 8254758
  43. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
    Nature. 1994 May 5;369(6475):31-7 PMID: 8164737
  44. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.
    J Infect Dis. 1994 May;169(5):956-61 PMID: 8169426
  45. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Virology. 1994 Jul;202(1):76-88 PMID: 7912023
  46. Cellular responses to interferon-gamma.
    Annu Rev Immunol. 1997;15:749-95 PMID: 9143706
  47. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.
    Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10289-94 PMID: 9294203
  48. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.
    J Virol. 1998 Jan;72(1):436-41 PMID: 9420243
  49. Protective immunity against HSV-2 in the mouse vagina.
    J Reprod Immunol. 1997 Nov 30;36(1-2):77-92 PMID: 9430740
  50. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.
    J Clin Invest. 1998 Apr 1;101(7):1500-8 PMID: 9525993
  51. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.
    J Immunol. 1997 Dec 1;159(11):5197-200 PMID: 9548456
  52. Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha.
    J Immunol. 1998 Jan 15;160(2):898-905 PMID: 9551927
  53. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Virology. 1995 Oct 1;212(2):481-9 PMID: 7571418
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2005-12-00
Pages
14546-54
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1287581
Subset
IM
Grants
NIAID NIH HHS · R01 AI042815 · United States
NIAID NIH HHS · R01 AI054444 · United States
NIAID NIH HHS · AI054444 · United States
NIAID NIH HHS · AI42815 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com